Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 41
1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we noninvasively measure blood sugar for diabetes?

Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

T Cell Vaccines as an Immunotherapy for Type 1 Diabetes

Type 1 Diabetes develops when CD4+ T cells aren't taught to differentiate between self-antigens and foreign...

Backer Badge Funded